PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Annals of Oncology10.1016/s0923-7534(20)31962-1201223xi18Phase II Trial of TS-1 in Combination with Oxaliplatin (SOX) in Patients with Metastatic Breast Cancer (MBC) Previously Treated with Anthracycline and Taxane Chemotherapy [TORCH] [Korean Cancer Study Group (KCSG) BR07-03]S.-A. Im, K.H. Lee, D.-Y. Oh, K.S. Lee, J.-H. Ahn, J. Sohn, J.S. Ahn, J.H. Kim, M.H. Lee, K.E. Lee, S.-Y. Kim, S.B. Kim, Y.-H. Im, J. Ro, H.-S. Parkhttps://api.elsevier.com/content/article/PII:S0923753420319621?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753420319621?httpAccept=text/plain
Cancer Research and Treatment10.4143/crt.2022.13602023552523-530A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03)Dae-Won Lee, Bhumsuk Keam, Keun Seok Lee, Jin-Hee Ahn, Joohyuk Sohn, Jin Seok Ahn, Moon Hee Lee, Jee Hyun Kim, Kyung Eun Lee, Hyo Jung Kim, Si-Young Kim, Yeon Hee Park, Chan-Young Ock, Kyung-Hun Lee, Sae-Won Han, Sung-Bae Kim, Young Hyuck Im, Hyun Cheol Chung, Do-Youn Oh, Seock-Ah Imhttp://e-crt.org/upload/pdf/crt-2022-1360.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2022.1360, http://e-crt.org/upload/pdf/crt-2022-1360.pdf
Community Oncology10.1016/s1548-5315(12)70002-520118115-17Eribulin in patients with metastatic breast cancer previously treated with an anthracycline and a taxaneJame Abrahamhttps://api.elsevier.com/content/article/PII:S1548531512700025?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1548531512700025?httpAccept=text/plain
Clinical Breast Cancer10.3816/cbc.2005.n.00920056155-60A Phase II Trial of Gemcitabine in Patients with Metastatic Breast Cancer Previously Treated with an Anthracycline and TaxaneShanu Modi, Violante E. Currie, Andrew D. Seidman, Ariadne M. Bach, Katherine S. Panageas, Maria Theodoulou, Mark M. Moasser, Gabriella M. D'Andrea, Diana E. Lake, Jennifer Choi, Larry Norton, Clifford A. Hudishttps://api.elsevier.com/content/article/PII:S1526820911707029?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1526820911707029?httpAccept=text/plain
Clinical Breast Cancer10.1016/j.clbc.2012.09.0072012126387-391North Central Cancer Treatment Group (NCCTG) N0537: Phase II Trial of VEGF-Trap in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and/or a TaxaneKostandinos Sideras, Amylou C. Dueck, Timothy J. Hobday, Kendrith M. Rowland, Jacob B. Allred, Donald W. Northfelt, Wilma L. Lingle, Robert J. Behrens, Tom R. Fitch, Daniel A. Nikcevich, Edith A. Perezhttps://api.elsevier.com/content/article/PII:S1526820912001875?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1526820912001875?httpAccept=text/plain
Clinical Breast Cancer10.1016/j.clbc.2015.08.002201616123-30N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing TherapyJennifer A. Crozier, Pooja P. Advani, Betsy LaPlant, Timothy Hobday, Anthony J. Jaslowski, Alvaro Moreno-Aspitia, Edith A. Perezhttps://api.elsevier.com/content/article/PII:S152682091500169X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S152682091500169X?httpAccept=text/plain
Clinical Breast Cancer10.3816/cbc.2001.n.01020012147-51Activity of Pemetrexed (ALIMTA®, Multitargeted Antifolate, LY231514) in Metastatic Breast Cancer Patients Previously Treated with an Anthracycline and a Taxane: An Interim AnalysisMarc Spielmann, Miguel Martin, Moïse Namer, Andreas duBois, Clemens Unger, David J. Dodwellhttps://api.elsevier.com/content/article/PII:S1526820911703214?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1526820911703214?httpAccept=text/plain
Clinical Breast Cancer10.3816/cbc.2007.n.003200776465-470Phase II Trial of Capecitabine and Weekly Paclitaxel in Patients with Metastatic Breast Cancer Previously Treated with Every-3-Week Taxane TherapyJoanne L. Blum, E. Claire Dees, Svetislava J. Vukelja, Mammo Amare, David P. Gill, Richard T. McMahon, Des Ilegbodu, Lina Asmar, Joyce A. O'Shaughnessyhttps://api.elsevier.com/content/article/PII:S1526820911707327?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1526820911707327?httpAccept=text/plain
Clinical Breast Cancer10.3816/cbc.2002.n.006200224299-303Phase I/II Trial of Gemcitabine Plus Cyclophosphamide in Patients with Metastatic Breast Carcinoma Previously Treated with TaxanesHuda S. Salman, Katie Tanaka, Joseph A. Sparanohttps://api.elsevier.com/content/article/PII:S1526820911704293?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1526820911704293?httpAccept=text/plain
BioDrugs10.1007/s40259-013-0038-12013275469-478Evolving Approaches to Metastatic Breast Cancer Patients Pre-treated with Anthracycline and TaxaneShigehira Sajihttp://link.springer.com/article/10.1007/s40259-013-0038-1/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40259-013-0038-1.pdf, http://link.springer.com/content/pdf/10.1007/s40259-013-0038-1